Fourth quarter and full year 2023 results
Fourth quarter and full year 2023 results were reviewed by management during a live audio webcast with the financial community on February 1st, 2024. The presentation was followed by a Q&A session.
Upcoming events
25Apr
First quarter 2024 results
First quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on April 25th, 2024. The presentation will be followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EST)
Quarterly Results
30Apr
General Meeting 2024
The Sanofi General Meeting will be held on April 30, 2024 at 02:30pm (CET) in the “Blue Amphitheatre” at the Palais des Congrès in Paris, Porte Maillot.
For any questions relating to this event, you can contact us from Monday to Friday from 09:00am to 06:00pm (CET) from France (free call from a landline): +33 800 800 826.
14:30 - 16:30
Annual General Meeting (AGM)
25Jul
Second quarter 2024 results
Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on July 25th, 2024. The presentation will be followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EST)
Quarterly Results
Press releases
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
To join the Sanofi front desk,
Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00
To contact the Investor Relations team:
46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com